tiprankstipranks
Mochida Pharmaceutical Co., Ltd. (JP:4534)
:4534
Japanese Market
4534
Mochida Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4534 full AI Analyst Report?

Mochida Pharmaceutical Co., Ltd. (4534) Income Statement

1 Followers

Mochida Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q1 2025), Mochida Pharmaceutical Co., Ltd.'s total revenue was ¥26.63B, an increase of 4.82% from the same quarter last year. In Q1, Mochida Pharmaceutical Co., Ltd.'s net income was ¥1.89B. See Mochida Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 116.95B¥ 105.16B¥ 102.89B¥ 103.26B¥ 110.18B
Gross Profit
¥ 56.26B¥ 53.79B¥ 52.07B¥ 55.12B¥ 59.55B
Operating Expenses
¥ 46.11B¥ 45.66B¥ 46.27B¥ 46.61B¥ 45.16B
Depreciation and Amortization
¥ 2.98B¥ 2.94B¥ 2.81B¥ 2.67B¥ 2.69B
EBITDA
¥ 13.13B¥ 11.07B¥ 8.61B¥ 11.18B¥ 17.08B
Operating Income
¥ 10.15B¥ 8.13B¥ 5.80B¥ 8.51B¥ 14.39B
Other Income/Expenses
¥ 1.02B¥ -75.00M¥ 357.00M¥ 536.00M¥ 199.00M
Pretax Income
¥ 11.17B¥ 8.05B¥ 6.16B¥ 9.04B¥ 14.59B
Net Income
¥ 7.90B¥ 5.68B¥ 4.55B¥ 6.65B¥ 10.57B
Per Share Metrics
Basic EPS
¥ 222.93¥ 160.36¥ 126.79¥ 178.93¥ 277.39
Diluted EPS
¥ 222.93¥ 160.36¥ 126.79¥ 178.93¥ 277.39
Weighted Average Shares Outstanding
 35.45M 35.45M 35.86M 37.16M 38.10M
Weighted Average Shares Outstanding (Diluted)
 35.45M 35.45M 35.86M 37.16M 38.10M
Currency in JPY

Mochida Pharmaceutical Co., Ltd. Earnings and Revenue History